Fresh Tracks Therapeutics | SC 13D: Statement of acquisition of beneficial ownership by individuals-Stephen L. Gustin(21.3%),Exploration Capital, LLC(20.5%)
Fresh Tracks Therapeutics | SC 13D: Statement of acquisition of beneficial ownership by individuals-Stephen L. Gustin(21.3%),Exploration Capital, LLC(20.5%)
Fresh Tracks Therapeutics | SC 13D：超過5%持股股東披露文件-Stephen L. Gustin(21.3%),Exploration Capital, LLC(20.5%)
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。